Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Calcifar Plus
- Development stage
- Unknown
- Lead developer
- Farabi
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Calcifar Plus is an oral dietary supplement developed and manufactured by Farabi Pharmaceutical Company. Formulated as enteric-coated tablets, it contains a combination of essential minerals and vitamins, including calcium, magnesium, zinc, vitamin D3 (cholecalciferol), and vitamin K1 (phytomenadione). This combination is designed to support bone and teeth health, enhance bone matrix formation, and prevent bone loss associated with conditions like osteoporosis. Calcium and magnesium serve as critical structural components of bone, while zinc supports bone tissue repair and growth. Vitamin D3 promotes the absorption of calcium and phosphorus from the intestine and regulates bone mineralization through the activation of the vitamin D receptor (VDR). Vitamin K1 acts as an essential cofactor for gamma-glutamyl carboxylase (GGCX), facilitating the carboxylation and activation of osteocalcin, a key protein required for binding calcium to the bone matrix.
- Brand names
- Calcifar Plus
- Other names
- Ca, Mg, Zn, D3, K1Calcium + Magnesium + Zinc + Vitamin D3 + Vitamin K1calcium + magnesium + zinc + cholecalciferol + phytomenadione
02
Targets
CaSR (Extracellular calcium-sensing receptor)GGCX (Vitamin K-dependent gamma-glutamyl carboxylase)VDR (Vitamin D receptor)VKORC1 (Vitamin K epoxide reductase complex subunit 1)
Beyond the preview
Go deeper on Calcifar Plus.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Calcifar Plus.